News + Filings Transactions
|
Flaherty Keith T.
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/13/2022 | Kinnate Biopharma Inc. | | Grant | Stock Option (right to buy) | 20.2k | $8.38 | $169.7k | | 06/13/2022 |
| 05/31/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Disposition | Stock Option (Right to Buy) | 10k | $6.27 | $62.9k | | 05/31/2022 |
| 05/31/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Disposition | Stock Option (Right to Buy) | 4k | $2.47 | $9.9k | | 05/31/2022 |
| 05/31/2022 | Checkmate Pharmaceuticals, Inc. | CMPI | Disposition | Stock Option (Right to Buy) | 22.7k | $2.62 | $59.6k | | 05/31/2022 |
| 06/16/2021 | Checkmate Pharmaceuticals, Inc. | CMPI | Grant | Stock Option (Right to Buy) | 10k | $6.27 | $62.9k | | 06/16/2021 |
| 06/11/2021 | Kinnate Biopharma Inc. | | Grant | Stock Option (right to buy) | 20.2k | $24.46 | $495.3k | | 06/11/2021 |
| 06/10/2021 | Clovis Oncology, Inc. | CLVS | Grant | Stock Option (right to buy) | 42.2k | $5.97 | $252.1k | | 06/10/2021 |
| 06/04/2020 | Clovis Oncology, Inc. | CLVS | Grant | Stock Option (right to buy) | 40.1k | $6.48 | $260.1k | | 06/04/2020 |
| 06/06/2019 | Clovis Oncology, Inc. | CLVS | Grant | Stock Option (right to buy) | 28.9k | $14.66 | $423.4k | | 06/06/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 8.8k | $180.98 | $1.6M | | 02/15/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 2.5k | $84.88 | $212.2k | | 02/15/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Common Stock | 9.7k | $235.00 | $2.3M | | 02/15/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 32.3k | $1.18 | $38.3k | | 02/15/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 68.6k | $1.18 | $81.2k | | 02/15/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 31.5k | $3.65 | $114.8k | | 02/15/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 15.6k | $13.00 | $203.1k | | 02/15/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 12.5k | $13.67 | $170.9k | | 02/15/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 7.8k | $20.91 | $163.3k | | 02/15/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 7.8k | $24.18 | $188.9k | | 02/15/2019 |
| 02/15/2019 | Loxo Oncology, Inc. | LOXO | Disposition | Employee Stock Option (Right to Buy) | 11k | $78.58 | $864.4k | | 02/15/2019 |
| 10/11/2018 | Clovis Oncology, Inc. | CLVS | Grant | Stock Option (right to buy) | 14.8k | $27.92 | $412.4k | | 10/11/2018 |
| 06/13/2018 | Loxo Oncology, Inc. | LOXO | Grant | Director Stock Option (right to buy) | 8.8k | $180.98 | $1.6M | | 06/13/2018 |
| 06/07/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 1.9k | $169.85 | $322.7k | | 06/07/2018 |
| 06/07/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 5k | $171.15 | $859.4k | | 06/07/2018 |
| 06/07/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 4.6k | $172.03 | $797.2k | | 06/07/2018 |
| 06/07/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 12.2k | $173.32 | $2.1M | | 06/07/2018 |
| 06/07/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 16k | $174.04 | $2.8M | | 06/07/2018 |
| 06/07/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 4.7k | $175.10 | $830.5k | | 06/07/2018 |
| 06/07/2018 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 5.4k | $175.97 | $954.1k | | 06/07/2018 |
| 06/07/2018 | Loxo Oncology, Inc. | LOXO | Exercise | Director Stock Option (right to buy) | 50k | $1.18 | $59.2k | | 06/07/2018 |
| 01/04/2018 | Loxo Oncology, Inc. | LOXO | Grant | Director Stock Option (right to buy) | 2.5k | $84.88 | $212.2k | | 01/04/2018 |
| 11/20/2017 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 2k | $77.33 | $151.6k | | 11/20/2017 |
| 11/20/2017 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 800 | $76.29 | $61k | | 11/20/2017 |
| 11/20/2017 | Loxo Oncology, Inc. | LOXO | Sale | Common Stock | 4.5k | $75.35 | $338.2k | | 11/20/2017 |
| 06/22/2017 | Loxo Oncology, Inc. | LOXO | Grant | Director Stock Option (right to buy) | 11k | $78.58 | $864.4k | | 06/22/2017 |
|
|